Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Insulin aspart is a rapid-acting human insulin analog used to improve glycemic control in adults and children with diabetes mellitus. Current U.S. products include U-100 formulations and newer biosimilar products. Product-specific instructions govern injection devices, pumps, and meal timing.
read more about insulin aspart ...Insulin aspart increases glucose uptake in skeletal muscle and fat and decreases glucose production in the liver. It also reduces lipolysis and proteolysis and increases protein synthesis. Its rapid onset makes it suitable for meal-time insulin therapy.
Insulin aspart is used in adults and pediatric patients with diabetes mellitus when rapid-acting insulin is part of the treatment regimen. Standard U-100 insulin aspart can be given by subcutaneous injection, compatible insulin pumps, or intravenous infusion under medical supervision.
Dosing is individualized according to metabolic needs, blood glucose results, meals, activity, and the rest of the insulin regimen. Standard U-100 insulin aspart corresponding to NovoLog is injected 5 to 10 minutes before a meal. Pump and intravenous administration follow product-specific instructions.
Hypoglycemia is the most serious insulin-related risk and can cause seizures, unconsciousness, or death. Other concerns include hypokalemia, severe hypersensitivity, medication errors, lipodystrophy, localized cutaneous amyloidosis, and fluid retention with thiazolidinediones. Pump malfunction can rapidly cause hyperglycemia and ketoacidosis.
Insulin aspart is a rapid-acting human insulin analog.
The current NovoLog-based labeling directs injection 5 to 10 minutes before a meal.
Yes. Compatible U-100 insulin aspart products can be used in insulin pumps according to the pump and product instructions.
Yes. Insulin can shift potassium into cells and cause hypokalemia.
Aspart Insulin. https://www.ncbi.nlm.nih.gov/books/NBK500030/. Date Accessed October 5, 2026.
Diabetes Treatments. https://www.novonordisk-us.com/products/diabetes.html. Date Accessed October 5, 2026.
Insulin Aspart (rDNA Origin) Injection: MedlinePlus Drug Information. https://medlineplus.gov/druginfo/meds/a605013.html. Date Accessed October 5, 2026.
Insulin Aspart Injection Prescribing Information. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bee5b358-c863-420b-be73-ced2e920c499. Date Accessed October 5, 2026.
NOVOLOG (Insulin Aspart) Prescribing Information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e172b4f8-9b25-4019-8e09-afc10b2f30c9. Date Accessed October 5, 2026.